Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124601015 | 12460101 | 5 | F | 20160812 | 20160613 | 20160818 | PER | US-PFIZER INC-2016285762 | PFIZER | 81.00 | YR | M | Y | 71.66000 | KG | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124601015 | 12460101 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (2 WEEKS ON/1 WEEK OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 124601015 | 12460101 | 2 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 124601015 | 12460101 | 3 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124601015 | 12460101 | 1 | Metastatic renal cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124601015 | 12460101 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124601015 | 12460101 | Asthenia | |
| 124601015 | 12460101 | Blister | |
| 124601015 | 12460101 | Blood count abnormal | |
| 124601015 | 12460101 | Blood pressure increased | |
| 124601015 | 12460101 | Chills | |
| 124601015 | 12460101 | Depression | |
| 124601015 | 12460101 | Diarrhoea | |
| 124601015 | 12460101 | Dizziness | |
| 124601015 | 12460101 | Dry skin | |
| 124601015 | 12460101 | Dysgeusia | |
| 124601015 | 12460101 | Feeling jittery | |
| 124601015 | 12460101 | Haemoglobin abnormal | |
| 124601015 | 12460101 | Haemoglobin decreased | |
| 124601015 | 12460101 | Malaise | |
| 124601015 | 12460101 | Productive cough | |
| 124601015 | 12460101 | Red blood cell count decreased | |
| 124601015 | 12460101 | Rhinorrhoea | |
| 124601015 | 12460101 | Skin lesion | |
| 124601015 | 12460101 | Sleep disorder | |
| 124601015 | 12460101 | Weight decreased | |
| 124601015 | 12460101 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124601015 | 12460101 | 1 | 20160428 | 0 |